Metformin-Associated Lactic Acidosis Development and Management

Pathophysiology and Risk Factors

Metformin is primarily cleared by the kidneys, and toxic levels can accumulate when renal function is impaired or with acute overdose, as noted by the American Journal of Kidney Diseases 1, 2
Decreased kidney function significantly accelerates metformin accumulation and hastens lactic acidosis development, according to the American Journal of Kidney Diseases 1, 2, 3
Pre-existing conditions such as liver disease, heart failure, or respiratory failure can accelerate lactic acidosis development, as reported in Kidney International 4

Initial symptoms of metformin-associated lactic acidosis may include nausea, vomiting, abdominal pain, and malaise, as described in the American Journal of Kidney Diseases 2
Patients with eGFR <30 ml/min/1.73 m² should not use metformin due to increased risk of lactic acidosis, as recommended by Kidney International 4
Metformin should be temporarily discontinued during periods of acute illness that may affect kidney function, as advised by Praxis Medical Insights 5

Metformin should be dosed appropriately based on renal function, as recommended by Kidney International 4
For patients with eGFR 30-44 ml/min/1.73 m², metformin dose should be reduced to 1000 mg daily, according to Kidney International 4
Patients should be educated about "sick day rules" - to temporarily stop metformin during any acute illness that may affect kidney function, as suggested by Praxis Medical Insights 5